Silver nanoparticles: A new view on mechanistic aspects on antimicrobial activity

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 12, Issue 3, 2016, Pages 789-799

  Durán, Nelson ^a,b   Durán, Marcela ^a   de Jesus, Marcelo Bispo ^a   Seabra, Amedea B ^c   Fávaro, Wagner J ^a   Nakazato, Gerson ^d  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b BRAZILIAN CENTER FOR RESEARCH IN ENERGY AND MATERIALS CNPEM   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

Antibacterial; Bacterial resistance; Silver nanoparticles; Toxicity

Indexed keywords

ANTIMICROBIAL AGENTS; CYTOLOGY; FREE RADICALS; METAL IONS; METAL NANOPARTICLES; MICROORGANISMS; NANOPARTICLES; TOXICITY;

ANTI-BACTERIAL ACTIVITY; ANTI-MICROBIAL ACTIVITY; ANTIBACTERIAL; ANTIMICROBIAL MECHANISMS; BACTERIAL RESISTANCE; CELL MEMBRANE DAMAGES; FREE RADICAL GENERATION; SILVER NANOPARTICLES;

SILVER;

FREE RADICAL; SILVER NANOPARTICLE; ANTIINFECTIVE AGENT; BACTERIAL DNA; BACTERIAL PROTEIN; METAL NANOPARTICLE; SILVER;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; CELL MEMBRANE; MEMBRANE DAMAGE; NONHUMAN; PROTEIN LIPID INTERACTION; REVIEW; ANIMAL; BACTERIAL INFECTIONS; BACTERIUM; CHEMISTRY; DNA DAMAGE; DRUG EFFECTS; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; LIPID METABOLISM; METABOLISM; MICROBIOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; BACTERIAL PROTEINS; DNA DAMAGE; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FREE RADICALS; HUMANS; LIPID METABOLISM; METAL NANOPARTICLES; SILVER;

EID: 84959450124     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2015.11.016     Document Type: Review

References (100)

1. Neal A.L. What can be inferred from bacterium-nanoparticle interactions about the potential consequences of environmental exposure to nanoparticles?. Ecotoxicology 2008, 17:362-371.
2. Chopra I. The increasing use of silver-based products as antimicrobial agents: a useful development or a cause for concern?. J Antimicrob Chemother 2007, 59:587-590.
3. Tian J., Wong K.K.Y., Ho C.-M., Lok C.-N., Yu W.-Y., Che C.-M., et al. Topical delivery of silver nanoparticles promotes wound healing. Chem Med Chem 2007, 2:129-136.
4. Lok C.-N., Ho C.-M., Chen R., He Q.-Y., Yu W.-Y., Sun H., et al. Silver nanoparticles: partial oxidation and antibacterial activities. J Biol Inorg Chem 2007, 12:527-534.
5. Lok C.-N., Ho C.-M., Chen R., He Q.-Y., Yu W.-Y., Sun H., et al. Proteomic analysis of the mode of antibacterial action of silver nanoparticles. J Proteome Res 2006, 5:916-924.
6. Cardozo V.F., Oliveira A.G., Nishio E.K., Perugini M.R.E., Andrade C.G.T., Silveira W.D., et al. Antibacterial activity of extracellular compounds produced by a Pseudomonas strain against methicillin-resistant Staphylococcus aureus (MRSA) strains. Ann Clin Microbiol Antimicrob 2013, 12:12.
7. Biasi-Garbin R.P., Otaguiri E.S., Morey A.T., da Silva M.F., Morguette A.E.B., Lancheros C.A.C., et al. Effect of eugenol against Streptococcus agalactiae and synergistic interaction with biologically produced silver nanoparticles. Evid Based Complement Alternat Med 2015, 10.1155/2015/861497.
8. Wong K.K.Y., Liu X. Silver nanoparticles-the real "silver bullet" in clinical medicine?. Med Chem Commun 2010, 1:125-131.
9. Durán N., Marcato P.D., De Conti R., Alves O.L., Costa F.T.M., Brocchi M. Potential use of silver nanoparticles on pathogenic bacteria, their toxicity and possible mechanisms of action. J Braz Chem Soc 2010, 21:949-959.
10. Marambio-Jones C., Hoek E.M.V. A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment. J Nanopart Res 2010, 12:1531-1551.
11. Prabhu S., Poulose E.K. Silver nanoparticles: mechanism of antimicrobial action, synthesis, medical applications, and toxicity effects. Int Nano Lett 2012, 2:32.
12. Rai M.K., Deshmukh S.D., Ingle A.P., Gade A.K. Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteria. J Appl Microbiol 2012, 112:841-852.
13. Kon K., Rai M. Metallic nanoparticles: mechanism of antibacterial action and influencing factors. J Comp Clin Path Res 2013, 1:160-174.
14. Mirzajani F., Ghassempour A., Aliahmadi A., Esmaeili M.A. Antibacterial effect of silver nanoparticles on Staphylococcus aureus. Res Microbiol 2011, 162:542-549.
15. McQuillan J.S., Groenaga Infante H., Stokes E., Shaw A.M. Silver nanoparticle enhanced silver ion stress response in Escherichia coli K12. Nanotoxicology 2012, 6:857-866.
16. Kim J.S., Kuk E., Yu K.N., Kim J.-H., Park S.J., Lee H.J., et al. Antimicrobial effects of silver nanoparticles. Nanomedicine: NBM 2007, 3:95-101.
17. Lemire J.A., Harrison J.J., Turner R.J. Antimicrobial activity of metals: mechanisms, molecular targets and applications. Nat Rev Microbiol 2013, 11:371-384.
18. Gans J., Wolinsky M., Dunbar J. Computational improvements reveal great bacterial diversity and high metal toxicity in soil. Science 2005, 309:1387-1390.
19. Reidy B., Haase A., Luch A., Dawson K.A., Lynch I. Mechanisms of silver nanoparticle release, transformation and toxicity: a critical review of current knowledge and recommendations for future studies and applications. Materials 2013, 6:2295-2350.
20. Li Q., Mahendra S., Lyon D.Y., Brunet L., Liga M.V., Li D., et al. Antimicrobial nanomaterials for water disinfection and microbial control: potential applications and implications. Water Res 2008, 42:4591-4602.
21. Cao H., Liu X., Meng F., Chu P.K. Silver nanoparticles-modified films versus biomedical device-associated infections. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2010, 2:670-684.
22. Cao H., Liu X., Meng F., Chu P.K. Biological actions of silver nanoparticles embedded in titanium controlled by micro-galvanic effects. Biomaterials 2011, 32:693-705.
23. Xiu Z.M., Zhang Q.B., Puppala H.L., Colvin L., Alvarez P.J. Negligible particle-specific antibacterial activity of silver nanoparticles. Nano Lett 2012, 12:4271-4275.
24. Pal S., Tak Y.K., Song J.M. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli. Appl Environ Microbiol 2007, 73:1712-1720.
25. Manke A., Wang L., Rojanasakul Y. Mechanisms of nanoparticle-induced oxidative stress and toxicity. BioMed Res Int 2013, 2013.
26. Rajeshkumar S., Malarkodi C. In vitro antibacterial activity and mechanism of silver nanoparticles against foodborne pathogens. Bioinorg Chem Appl 2014, 2014.
27. Santos C.A., Seckler M.M., Ingle A.P., Gupta I., Galdiero S., Galdiero M.A., et al. Silver nanoparticles: therapeutical uses, toxicity and safety issues. J Pharm Sci 2014, 103:1931-1944.
28. Wu J., Yu C., Tan Y., Hou Z., Li M., Shao F., et al. Effects of prenatal exposure to silver nanoparticles on spatial cognition and hippocampal neurodevelopment in rats. Environ Res 2015, 138C:67-73.
29. Navarro E., Piccapietra F., Wagner B., Marconi F., Kaegi R., Odzak N., et al. Toxicity of silver nanoparticles to Clamydomona sreinhardtii. Environ Sci Technol 2008, 42:8959-8964.
30. 2 coatings?. New J Chem 2014, 38:3275-3281.
31. Ivask A., El-Badawy A., Kaweeteerawat C., Boren D., Fischer H., Ji Z., et al. Toxicity mechanisms in Escherichia coli vary for silver nanoparticles and differ from ionic silver. ACS Nano 2014, 8:374-386.
32. Ivask A., Kurvet I., Kasemets K., Blinova I., Aruoja V., Suppi S., et al. Size-dependent toxicity of silver nanoparticles to bacteria, yeast, algae, crustaceans and mammalian cells in vitro. PLoS One 2014, 9.
33. Palza H. Antimicrobial polymers with metal nanoparticles. Int J Mol Sci 2015, 16:2099-2116.
34. Hsiao I.L., Hsieh Y.K., Wang C.F., Chen I.C., Huang Y.J. Trojan-horse mechanism in the cellular uptake of silver nanoparticles verified by direct intra- and extracellular silver speciation analysis. Environ Sci Technol 2015, 10.1021/es504705p.
35. Liu J., Sonshine D.A., Shervani S., Hurt R.H. Controlled release of biologically active silver from nanosilver surfaces. ACS Nano 2010, 4:6903-6913.
36. Zande M., Vandebriel R.J., Doren E.V., Kramer E., Rivera Z.H., Serrano-Rojero C.S., et al. Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure. ACS Nano 2012, 6:7427-7442.
37. Agnihotri S., Mukherji S., Mukherji S. Immobilized silver nanoparticles enhance contact killing and show highest efficacy: elucidation of the mechanism of bactericidal action of silver. Nanoscale 2013, 5:7328-7340.
38. Radzig M.A., Nadtochenko V.A., Koksharova O.A., Kiwi J., Lipasova V.A., Khmela I.A. Antibacterial effects of silver nanoparticles on gram-negative bacteria: influence on the growth and biofilms formation, mechanisms of action. Colloids Surf B Biointerfaces 2013, 102:300-306.
39. Abbaszadegan A., Ghahramani Y., Gholami A., Hemmateenejad B., Dorostkar S., Nabavizadeh M., et al. The effect of charge at the surface of silver nanoparticles on antimicrobial activity against gram-positive and gram-negative bacteria: a preliminary study. J Nanomat 2015 2015.
40. Prince H.N., Prince D.L. Orthopedic Dis. Technol http://www.odtmag.com/contents/view_features/2008-05-29/antimicrobial-silver-in-orthopedic-and-wound-#sthash.VpBc4IQO.dpuf.
41. Said J., Dodoo C., Walker M., Parsons D., Stapleton P., Beezer A.E., et al. An in vitro test of the efficacy of silver-containing wound dressings against Staphylococcus aureus and Pseudomonas aeruginosa in simulated wound fluid. Int J Pharm 2014, 462:123-128.
42. Choi O., Clevenger T.E., Deng B., Surampalli R.Y., Ross L., Hu Z. Role of sulfide and ligand strength in controlling nanosilver toxicity. Water Res 2009, 43:1879-1886.
43. Bondarenko O., Ivask A., Kakinen A., Kurvet I., Kahru A. Particle-cell contact enhances antibacterial activity of silver nanoparticles. PLoS One 2013, 8.
44. Li W.R., Xie X.B., Shi Q.S., Zeng H.Y., Ou-Yang Y.S., Chen Y.B. Antibacterial activity and mechanism of silver nanoparticles on Escherichia coli. Appl Microbiol Biotechnol 2010, 85:1115-1122.
45. Silhavy T.J., Kahne D., Walker S. The bacterial cell envelope. Cold Spring Harb Perspect Biol 2010, 2:a000414.
46. Ahearn D.G., May L.L., Gabriel M.M. Adherence of organisms to silver-coated surfaces. J Ind Microbiol 1995, 15:372-376.
47. Morones J.R., Elechiguerra J.L., Camacho A., Holt K., Kouri J.B., Ramírez J.T., et al. The bactericidal effect of silver nanoparticles. Nanotechnology 2005, 16:2346-2353.
48. +. Biochemistry 2005, 44:13214-13223.
49. + in Vibrio cholera. Antimicrob Agents Chemother 2002, 46:2668-2670.
50. Hachicho N., Hoffmann P., Ahlert K., Heipieper H.J. Effect of silver nanoparticles and silver ions on growth and adaptive response mechanisms of Pseudomonas putida mt-2. FEMS Microbiol Lett 2014, 355:71-77.
51. 2 NC) with cell wall, metabolism and genetic stability of Pseudomonas aeruginosa, a multiple antibiotic-resistant bacterium. Lett Appl Microbiol 2013, 56:57-62.
52. Mueller-Spitz S.R., Crawford K.D. Silver nanoparticle inhibition of polycyclic aromatic hydrocarbons degradation by Mycobacterium species RJGII-135. Lett Appl Microbiol 2014, 58:330-337.
53. Ansari M.A., Khan H.M., Khan A.A., Ahmad M.K., Mahdi A.A., Pal R., et al. Interaction of silver nanoparticles with Escherichia coli and their cell envelope biomolecules. J Basic Microbiol 2014, 54:905-915.
54. Rajesh S., Dharanishanthi V., Kanna A.V. Antibacterial mechanism of biogenic silver nanoparticles of Lactobacillus acidophilus. J Exp Nanosci 2015, 10:1143-1152.
55. Sondi I., Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci 2004, 275:177-182.
56. Chwalibog A., Sawosz E., Hotowy A., Szeliga J., Mitura S., Mitura K., et al. Visualization of interaction between inorganic nanoparticles and bacteria or fungi. Int J Nanomed 2010, 5:1085-1094.
57. McDonnell G., Russell A.D. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev 1999, 12:147-179.
58. Devi L.S., Joshi S.R. Evaluation of the antimicrobial potency of silver nanoparticles biosynthesized by using an endophytic fungus, Cryptosporiopsis ericae PS4. J Microbiol 2014, 52:667-674.
59. Yuan Z., Li J., Cui L., Xu B., Zhang H., Yu C.-P. Interaction of silver nanoparticles with pure nitrifying bacteria. Chemosphere 2013, 90:1404-1411.
60. 3. Korean J Chem Eng 2011, 28:267-271.
61. Radniecki T.S., Stankus D.P., Neigh A., Nason J.A., Semprini L. Influence of liberated silver from silver nanoparticles on nitrification inhibition of Nitrosomonas europaea. Chemosphere 2011, 85:43-49.
62. Jung W.K., Koo H.C., Kim K.W., Shin S., Kim S.H., Park Y.H. Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli. Appl Environ Microbiol 2008, 74:2171-2178.
63. Chen M., Yang Z., Wu H., Pan X., Xie X., Wu C. Antimicrobial activity and the mechanism of silver nanoparticle thermosensitive gel. Int J Nanomed 2011, 6:2873-2877.
64. Vishnupriya S., Chaudhari K., Jagannathan R., Pradeep T. Single-cell investigations of silver nanoparticle-bacteria interactions. Single-Cell Part Part Syst Charact 2013, 30:1056-1062.
65. Ouda S.H. Some nanoparticles effects on Proteus sp. and Klebsiella sp. isolated from water. Am J Infect Dis Microbiol 2014, 2:4-10.
66. Danilczuk M., Lund A., Saldo J., Yamada H., Michalik J. Conduction electron spin resonance of small silver particles. Spectrochim Acta Part A 2006, 63:189-191.
67. Soo-Hwan K., Lee H.-S., Ryu D.-S., Choi S.-J., Lee D.-S. Antibacterial activity of silver-nanoparticles against Staphylococcus aureus and Escherichia coli. Korean J Microbiol Biotechnol 2011, 39:77-85.
68. Xu H., Qu F., Xu H., Lai W., Wang Y.A., Aguilar Z.P., et al. Role of reactive oxygen species in the antibacterial mechanism of silver nanoparticles on Escherichia coli O157:H7. Biometals 2012, 25:45-53.
69. Kora A.J., Sashidhar R.B. Biogenic silver nanoparticles synthesized with rhamnogalacturonan gum: antibacterial activity, cytotoxicity and its mode of action. Arabian J Chem 2015, 10.1016/j.arabjc.2014.10.036.
70. Choi O., Hu Z. Size dependent and reactive oxygen species related nanosilver toxicity to nitrifying bacteria. Environ Sci Technol 2008, 42:4583-4588.
71. Abbaszadegan A., Nabavizadeh M., Gholami A., Aleyasin Z.S., Dorostkar S., Saliminasab M., et al. Positively charged imidazolium-based ionic liquid-protected silver nanoparticles: a promising disinfectant in root canal treatment. Int Endod J 2015, 48:790-800.
72. + cations in bacteria: environments, genes and proteins. Met Based Drugs 1999, 6:315-320.
73. Mijnendonckx K., Leys N., Mahillon J., Silver S., VonHoudt R. Antimicrobial silver: uses, toxicity, and the potential for resistance. Biometals 2013, 26:609-621.
74. Mallard J.-E., Hartemann P. Silver as an antimicrobial: facts and gaps in knowledge. Crit Rev Microbiol 2013, 39:373-383.
75. Jelenko C. Silver nitrate resistant E. coli: report of case. Ann Surg 1969, 170:296-299.
76. McHugh G.L., Moellering R.C., Hopkins C.C., Swartz M.N. Salmonella typhimurium resistant to silver nitrate, chloramphenicol, and ampicillin. Lancet 1975, 1:235-240.
77. Davis I.J., Richards H., Mullany P. Isolation of silver- and antibiotic-resistant Enterobacter cloacae from teeth. Oral Microbiol Immunol 2005, 20:191-194.
78. Kremer A.N., Hoffmann H.J. Subtractive hybridization yields a silver resistance determinant unique to nosocomial pathogens in the Enterobacter cloacae complex. J Clin Microbiol 2012, 50:3249-3257.
79. Haefeli C., Franklin C., Hardy K. Plasmid-determined silver resistance in Pseudomonas stutzeri isolated from a silver mine. J Bacteriol 1984, 158:389-392.
80. Choudhury P., Kumar R. Multidrug- and metal-resistant strains of Klebsiella pneumoniae isolated from Penaeus monodon of the coastal waters of deltaic Sundarban. Can J Microbiol 1998, 44:186-189.
81. Holland S.L., Dyer P.S., Bond C.J., James S., Roberts I.N., Avery S.V. Candida argentea sp. nov., a copper and silver resistant yeast species. Fungal Biol 2011, 115:909-918.
82. Aminov R.I. Horizontal gene exchange in environmental microbiota. Front Microbiol 2011, 2:158. 10.3389/fmicb.2011.00158.
83. Heuer H., Kopmann C., Binh C.T., Top E.M., Smalla K. Spreading antibiotic resistance through spread manure: characteristics of a novel plasmid type with low %G + C content. Environ Microbiol 2009, 11:937-949.
84. Gupta A., Silver S. Silver as a biocide: will resistance become a problem?. Nat Biotechnol 1998, 16:868. 10.1038/nbt1098-888.
85. Graves J.L. A grain of salt: metallic and metallic oxide nanoparticles as the new antimicrobials. JSM Nanotechnol Nanomed 2014, 2:1026.
86. Graves J.L., Tajkarimi M., Cunningham Q., Campbell A., Nonga H., Harrison S.H., et al. Rapid evolution of silver nanoparticle resistance in Escherichia coli. Frontier Gent 2015, 6.
87. Baker C., Pradhan A., Pakstis L., Pochan D.J., Shah S.I. Synthesis and antibacterial properties of silver nanoparticles. J Nanosci Nanotechnol 2005, 5:244-249.
88. Gunawan G., Teoh W.Y., Marquis C.P., Lifia J., Amal R. Reversible antimicrobial photoswitching in nanosilver. Small 2009, 5:341-344.
89. Lee D., Cohen R.E., Rubner M.F. Antibacterial properties of Ag nanoparticle loaded multilayers and formation of magnetically directed antibacterial microparticles. Langmuir 2005, 21:9651-9659.
90. Wei L., Tang J., Zhang Z., Chen Y., Zhou G., Ci T. Investigation of the cytotoxicity mechanism of silver nanoparticles in vitro. Biomed Mater 2010, 5:044103. 10.1088/1748-6041/5/4/044103.
91. Wigginton N.S., Titta A., Piccapietra F., Dobias J., Nesatyy V.J., Suter M.J.F., et al. Binding of silver nanoparticles to bacterial proteins depends on surface modifications and inhibits enzymatic activity. Environ Sci Technol 2010, 44:2163-2168.
92. Samberg M.E., Orndorff P.E., Monteiro-Riviere N.A. Antibacterial efficacy of silver nanoparticles of different sizes, surface conditions and synthesis methods. Nanotoxicology 2011, 5:244-253.
93. Liu W., Wu Y., Wang C., Li H.C., Wang T., Lia C.Y., et al. Impact of silver nanoparticles on human cells: effect of particle size. Nanotoxicology 2010, 4:319-330.
94. Miyoshi H., Ohno H., Sakai K., Okamura N., Kourai H. Characterization and photochemical and antibacterial properties of highly stable silver nanoparticles prepared on montmorillonite clay in n-hexanol. J Colloid Interface Sci 2010, 345:433-441.
95. Kim S., Choi J.E., Choi J., Chung K.H., Park K., Yi J., et al. Oxidative stress dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicol In Vitro 2009, 23:1076-1084.
96. Kawata K., Osawa M., Okabe S. In vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells. Environ Sci Technol 2009, 43:6046-6051.
97. Su H.-L., Chou C.-C., Hung D.-J., Lin S.-H., Pao I.-C., Chiao S.-H., et al. The disruption of bacterial membrane integrity through ROS generation induced by nanohybrids of silver and clay. Biomaterials 2009, 30:5979-5987.
98. Hsu S.H., Tseng H.J., Lin Y.C. The biocompatibility and antibacterial properties of waterborne polyurethane-silver nanocomposites. Biomaterials 2010, 31:6796-6808.
99. Su H.-L., Lin S.-H., Wei J.-C., Pao I.-C., Chiao S.-H., Huang C.-C., et al. Novel nanohybrids of silver particles on clay platelets for inhibiting silver-resistant bacteria. PLoS One 2011, 6:e21125. 10.1371/journal.pone.0021125.
100. Franci G., Falanga A., Galdiero S., Palomba L., Rai M., Morelli G., et al. Silver nanoparticles as potential antibacterial agents. Molecules 2015, 20:8856-8874.